News & Updates
Filter by Specialty:
Functional surgery delivers amputation-free benefit in nail unit melanoma
Patients who have nail unit melanoma (NUM) with a Breslow thickness (BT) of <0.8 mm may benefit from functional surgery, which offers an amputation-sparing advantage, suggests a recent study.
Functional surgery delivers amputation-free benefit in nail unit melanoma
29 May 2023
HCT treatment tied to lower cancer risk, except skin cancer
Treatment with hydrochlorothiazide (HCT) contributes to a lower all-cancer risk and a slightly higher skin cancer risk compared with alternative diuretics, reports a study involving a German population.
HCT treatment tied to lower cancer risk, except skin cancer
26 May 2023
12-year review of HK Breast Cancer Registry: Neoadjuvant chemo effective in stage ≥II, HER2-positive and triple-negative disease
A 12-year review of Hong Kong Breast Cancer Registry (HKBCR) records of patients diagnosed with breast cancer in 2006–2017 showed that neoadjuvant chemotherapy (NAC) was effective in tumour downstaging, with one-fifth of patients subsequently achieving pathological complete response (pCR) in the breast and axillary lymph nodes. Patients with HER2-positive (nonluminal) and triple-negative disease were most likely to achieve pCR.
12-year review of HK Breast Cancer Registry: Neoadjuvant chemo effective in stage ≥II, HER2-positive and triple-negative disease
26 May 2023
Serum osteopontin levels predicts response to treatment in unresectable HCC
Among patients with unresectable hepatocellular carcinoma (HCC) scheduled to receive standard combination therapy with atezolizumab plus bevacizumab, those with high levels of serum osteopontin at baseline are likely to have poor response to treatment, as shown in a study.
